Cargando…

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)

BACKGROUND: Non-small cell lung cancer (NSCLC) is a leading cause of death worldwide. MicroRNAs (miRNAs) have been indicated as crucial actors in cancer biology. Accumulating evidence suggests that miRNAs can be used as diagnostic and prognostic markers for NSCLC. METHODS: The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xi, Chen, Si-yuan, Yang, Zhao, Zhang, Jie, Wang, Wei, Liu, Mei-yue, Niu, Yi, Wei, Xiao-mei, Li, Hong-min, Hu, Wan-ning, Sun, Guo-gui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145328/ https://www.ncbi.nlm.nih.gov/pubmed/30227870 http://dx.doi.org/10.1186/s13046-018-0882-4

Ejemplares similares

CircMMP9 accelerates the progression of hepatocellular carcinoma through the miR-149/CCND2 axis
por: Li, Xiaolou, et al.
Publicado: (2022)

MiR‐646 suppresses proliferation and metastasis of non‐small cell lung cancer by repressing FGF2 and CCND2
por: Wang, Jing, et al.
Publicado: (2020)

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)

LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC
por: Liu, Dongcheng, et al.
Publicado: (2022)

miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
por: Deng, Min, et al.
Publicado: (2013)

MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
por: Cheng, Zhenshun, et al.
Publicado: (2014)

The Fibroblast Growth Factor 9 (Fgf9) Participates in Palatogenesis by Promoting Palatal Growth and Elevation
por: Li, Ruomei, et al.
Publicado: (2021)

Fibroblast Growth Factor 9 (FGF9) negatively regulates the early stage of chondrogenic differentiation
por: Zhang, Xiaoyue, et al.
Publicado: (2021)

Fibroblast growth factor 9 (FGF9) inhibits myogenic differentiation of C2C12 and human muscle cells
por: Huang, Jian, et al.
Publicado: (2019)

MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2
por: Yin, Yali, et al.
Publicado: (2017)

Lactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice
por: Jacouton, Elsa, et al.
Publicado: (2015)

Effect of lentivirus-mediated miR-182 targeting FGF9 on hallux valgus
por: Zhang, Wei-Lin, et al.
Publicado: (2021)

Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors
por: Bao, Yilin, et al.
Publicado: (2021)

Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1
por: Sun, Cheng-Cao, et al.
Publicado: (2016)

4317 Using Failure Modes and Effects Analysis to Guide Adaptation of an Evidence-Based Parenting Program for Mothers with Substance Use Disorders
por: Peacock-Chambers, Elizabeth, et al.
Publicado: (2020)

Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines
por: Li, Hang, et al.
Publicado: (2019)

Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
por: Adélaide, J., et al.
Publicado: (1995)

FUBP3 interacts with FGF9 3′ microsatellite and positively regulates FGF9 translation
por: Gau, Bing-Huang, et al.
Publicado: (2011)

De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome
por: Mirzaa, Ghayda, et al.
Publicado: (2014)

Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p
por: Zhou, Lili, et al.
Publicado: (2020)

MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9
por: Liang, Zhihua, et al.
Publicado: (2019)

miR-187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2017)

Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis
por: Sun, Yang, et al.
Publicado: (2023)

Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas
por: Xu, Jia, et al.
Publicado: (2018)

Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2
Publicado: (1996)

MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1)
por: Zhu, Yong, et al.
Publicado: (2018)

[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9
por: Liang, Hua, et al.
Publicado: (2023)

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
por: Kryštof, Vladimír, et al.
Publicado: (2012)

Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes
por: Orfanidou, Timoklia, et al.
Publicado: (2009)

Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters
por: Mohammedi, Latifa, et al.
Publicado: (2019)

Down-Regulation of Fibroblast Growth Factor 2 (FGF2) Contributes to the Premature Senescence of Mouse Embryonic Fibroblast
por: Li, Jie, et al.
Publicado: (2020)

FGF6 and FGF9 regulate UCP1 expression independent of brown adipogenesis
por: Shamsi, Farnaz, et al.
Publicado: (2020)

Irradiation-Induced Activated Microglia Affect Brain Metastatic Colonization of NSCLC Cells via miR-9/CDH1 Axis
por: Jin, Yu, et al.
Publicado: (2021)

MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
por: Sun, Xionghua, et al.
Publicado: (2021)

miR-135a Suppresses Granulosa Cell Growth by Targeting Tgfbr1 and Ccnd2 during Folliculogenesis in Mice
por: Wang, Lei, et al.
Publicado: (2021)

Deletion of FGF9 in GABAergic neurons causes epilepsy
por: Guo, Moran, et al.
Publicado: (2021)

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
por: Saqub, Hera, et al.
Publicado: (2020)

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.
por: Betticher, D. C., et al.
Publicado: (1996)

Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma
por: Krieger, Sophie, et al.
Publicado: (2006)

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC
por: Wang, Sheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v98gnpqmi2867je85t9f16m9r4